The recommendations in this guideline apply to adult inpatients receiving myelosuppressive chemotherapy at Northern Light Eastern Maine Medical Center
Prophylaxis Plans Will Be Documented in Daily Progress Notes under ‘Infection Prophylaxis’
Deviations from the following recommendations may occur based on patient-specific risk-benefit considerations, and adequate documentation of such
> 3.5% risk of developing PCP
*Not an exhaustive list and risk should be determined for each regimen
EMMC - Pharmacist Review for Inpatients
Taplitz, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. 2018;36(30): 3034-3054.